Efficient chromosomal mapping of a methylcholanthrene-induced tumor antigen by CTL immunoselection

Journal of Immunology

Volumn 167, Issue 9, 2001, Pages 5143-5149

  Akilesh, S ^a   Dudley, M E ^a   Eden, P A ^a   Roopenian, D C ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; EPITOPE; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; CARCINOGENESIS; CHROMOSOME 4; CHROMOSOME MAP; CYTOTOXIC T LYMPHOCYTE; GENE LOCUS; GENETIC RECOMBINATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNITY; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; SOMATIC MUTATION;

EID: 0035500633     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.9.5143     Document Type: Article

References (41)

1. + T-cellstimulating peptide presented by a major histocompatibility complex class I molecule in a murine thymoma
2. Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells
3. Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes
4. Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp 100
5. Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: Implications for tumor vaccine development
6. Loss of heterozygosity and mitotic linkage maps in the mouse
7. Gene mapping in a murine cell line by immunoselection with cytotoxic T lymphocytes
8. Biochemical and immunogenetic analysis of an immunodominant peptide (B6dom1) encoded by the classical H7 minor histocompatibility locus
9. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones
10. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. VI. Occasional escape from host rejection due to antigen-loss secondary variants
11. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones
12. Deletion mapping by immunoselection against the H-Y histocompatibility antigen further resolves the Sxra region of the mouse Y chromosome and reveals complexity of the Hya locus
13. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens
14. Expression screening of a yeast artificial chromosome contig refines the location of the mouse H3a minor histocompatibility antigen gene
15. Positional cloning and molecular characterization of an immunodominant cytotoxic determinant of the mouse H3 minor histocompatibility complex
16. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes
17. + anti-Meth A cytotoxic T-lymphocytes: Recognition of an epitope derived from the Meth A gp110 tumor rejection antigen
18. - T-cell lines
19. Motif-primed polymerase chain reaction-based allelotype of sarcomas induced by 3-methylcholanthrene in interspecific hybrid mice
20. In vitro assays for mouse lymphocyte function
21. Using mitotic recombinant mutant clonal lymphocytes for physical mapping of polymorphic loci on the short arm of human chromosome 6
22. Mitotic recombination is responsible for the loss of heterozygosity in cultured murine cell lines
23. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling
24. Genetic studies of the relationship of tumour-host cells
25. Permanent modification (mutation?) of a histocompatibility gene in a heterozygous tumor
26. The H-2 complex and somatic cell genetics
27. Stepwise immunologic selection of antigenic variants during tumor growth
28. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes
29. Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma
30. IFN-γ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
31. Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia
32. Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in γ-radiatio-induced mouse primary thymic lymphomas
33. A new candidate site for a tumor suppressor gene involved in mouse thymic lymphomagenesis is located on the distal part of chromosome 4
34. Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis
35. Genomic organization and chromosomal location of murine Cdc42
36. A gene for susceptibility to small intestinal cancer, ssicl, maps to the distal part of mouse chromosome 4
37. High frequency of interactions between lung cancer susceptibility genes in the mouse: Mapping of Sluc5 to Sluc14
38. Genetic evaluation of candidate genes for the Mora1 modifier of intestinal neoplasia in mice
39. Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice
40. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: High frequency of chromosome 4 loss of heterozygosity at advanced stages of progression
41. Rejection antigens in chemically induced tumors